Predictors of Intra-aortic Balloon Pump Hemodynamic Failure in Non-acute Myocardial Infarction Cardiogenic Shock

Overview

Journal Am Heart J

Specialty Cardiology & Vascular Diseases

Date 2018 May 15

PMID 29754660

Citations 11

Authors

Steven Hsu

Swetha Kambhampati Thiruvengadam

Christopher M Sciortino

Stuart D Russell

Steven P Schulman

Affiliations

Soon will be listed here.

Abstract

Objectives: To characterize patient profile and hemodynamic profile of those undergoing intra-aortic balloon pump (IABP) for cardiogenic shock and define predictors of hemodynamic failure of IABP support.

Background: Clinical characteristics of IABP support in cardiogenic shock not related to acute myocardial infarction (AMI) remain poorly characterized.

Methods: We retrospectively studied a cohort of 74 patients from 2010 to 2015 who underwent IABP insertion for cardiogenic shock complicating acute decompensated heart failure not due to AMI.

Results: In the overall cohort, which consisted primarily of patients with chronic systolic heart failure (89%), IABP significantly augmented cardiac index and lowered systemic vascular resistance (P<.05). Despite this improvement, 28% of these patients died (24%) or require urgent escalation in mechanical circulatory support (MCS) (4%). Multivariable regression revealed that baseline left ventricular cardiac power index (LVCPI), a measure of LV power output derived from cardiac index and mean arterial pressure (P=.01), and history of ischemic cardiomyopathy (P=.003) were significantly associated with the composite adverse-event endpoint of death or urgent MCS escalation. An IABP Failure risk score using baseline LVCPI <0.28 W/m and ischemic history predicted 28-day adverse events with excellent discrimination.

Conclusion: Despite hemodynamic improvements with IABP support, patients with non-AMI cardiogenic shock still suffer poor outcomes. Patients with ischemic cardiomyopathy and low LVPCI fared significantly worse. These patients may warrant closer observation or earlier consideration of more advanced hemodynamic support.

Citing Articles

Current Landscape of Temporary Percutaneous Mechanical Circulatory Support Technology.

Upadhyay R, Alrayes H, Arno S, Kaushik M, Basir M US Cardiol. 2024; 15:e21.

PMID: 39720506 PMC: 11664789. DOI: 10.15420/usc.2021.15.

Non-acute myocardial infarction-associated cardiogenic shock in Hispanic patients: An analysis from the National Inpatient Sample Database.

Javed N, Jadhav P, Chilimuri S, Contreras J, Tamis-Holland J, Bella J Am Heart J Plus. 2024; 46:100462.

PMID: 39351148 PMC: 11440291. DOI: 10.1016/j.ahjo.2024.100462.

Bridge to Life: Current Landscape of Temporary Mechanical Circulatory Support in Heart-Failure-Related Cardiogenic Shock.

Vlachakis P, Theofilis P, Leontsinis I, Drakopoulou M, Karakasis P, Oikonomou E J Clin Med. 2024; 13(14).

PMID: 39064160 PMC: 11277937. DOI: 10.3390/jcm13144120.

Contemporary Evidence and Practice on Right Heart Catheterization in Patients with Acute or Chronic Heart Failure.

Manzi L, Sperandeo L, Forzano I, Castiello D, Florimonte D, Paolillo R Diagnostics (Basel). 2024; 14(2).

PMID: 38248013 PMC: 10814482. DOI: 10.3390/diagnostics14020136.

Utility of Cardiac Power Hemodynamic Measurements in the Evaluation and Risk Stratification of Cardiovascular Conditions.

Farshadmand J, Lowy Z, Hai O, Zeltser R, Makaryus A Healthcare (Basel). 2022; 10(12).

PMID: 36553940 PMC: 9777954. DOI: 10.3390/healthcare10122417.

References

Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L, Byrne R . A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008; 52(19):1584-8. DOI: 10.1016/j.jacc.2008.05.065. View

Berg D, Sukul D, OBrien M, Scirica B, Sobieszczyk P, Olenchock B . Outcomes in patients undergoing percutaneous ventricular assist device implantation for cardiogenic shock. Eur Heart J Acute Cardiovasc Care. 2015; 5(2):108-16. PMC: 4627853. DOI: 10.1177/2048872615584079. View

Aaronson K, Schwartz J, Chen T, Wong K, Goin J, Mancini D . Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997; 95(12):2660-7. DOI: 10.1161/01.cir.95.12.2660. View

Popovic B, Fay R, Cravoisy-Popovic A, Levy B . Cardiac power index, mean arterial pressure, and Simplified Acute Physiology Score II are strong predictors of survival and response to revascularization in cardiogenic shock. Shock. 2014; 42(1):22-6. DOI: 10.1097/SHK.0000000000000170. View

Thiele H, Zeymer U, Neumann F, Ferenc M, Olbrich H, Hausleiter J . Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. 2013; 382(9905):1638-45. DOI: 10.1016/S0140-6736(13)61783-3. View

Visveswaran G, Cohen M, Seliem A, DiVita M, McNamara J, Dave A . A single center tertiary care experience utilizing the large volume mega 50cc intra-aortic balloon counterpulsation in contemporary clinical practice. Catheter Cardiovasc Interv. 2017; 90(4):E63-E72. DOI: 10.1002/ccd.26908. View

Thiele H, Zeymer U, Neumann F, Ferenc M, Olbrich H, Hausleiter J . Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012; 367(14):1287-96. DOI: 10.1056/NEJMoa1208410. View

Ouweneel D, Eriksen E, Sjauw K, van Dongen I, Hirsch A, Packer E . Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol. 2016; 69(3):278-287. DOI: 10.1016/j.jacc.2016.10.022. View

Rigamonti F, Graf G, Merlani P, Bendjelid K . The short-term prognosis of cardiogenic shock can be determined using hemodynamic variables: a retrospective cohort study*. Crit Care Med. 2013; 41(11):2484-91. DOI: 10.1097/CCM.0b013e3182982ac3. View

10.

Shekar K, Gregory S, Fraser J . Mechanical circulatory support in the new era: an overview. Crit Care. 2016; 20:66. PMC: 4794944. DOI: 10.1186/s13054-016-1235-3. View

11.

Lang C, Karlin P, Haythe J, Lim T, Mancini D . Peak cardiac power output, measured noninvasively, is a powerful predictor of outcome in chronic heart failure. Circ Heart Fail. 2009; 2(1):33-8. DOI: 10.1161/CIRCHEARTFAILURE.108.798611. View

12.

van Nunen L, Noc M, Kapur N, Patel M, Perera D, Pijls N . Usefulness of Intra-aortic Balloon Pump Counterpulsation. Am J Cardiol. 2015; 117(3):469-76. DOI: 10.1016/j.amjcard.2015.10.063. View

13.

Fincke R, Hochman J, Lowe A, Menon V, Slater J, Webb J . Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol. 2004; 44(2):340-8. DOI: 10.1016/j.jacc.2004.03.060. View

14.

Papaioannou T, Terrovitis J, Kanakakis J, Stamatelopoulos K, Protogerou A, Lekakis J . Heart rate effect on hemodynamics during mechanical assistance by the intra-aortic balloon pump. Int J Artif Organs. 2003; 25(12):1160-5. DOI: 10.1177/039139880202501207. View

15.

Santa-Cruz R, Cohen M, Ohman E . Aortic counterpulsation: a review of the hemodynamic effects and indications for use. Catheter Cardiovasc Interv. 2005; 67(1):68-77. DOI: 10.1002/ccd.20552. View

16.

Ouweneel D, Eriksen E, Seyfarth M, Henriques J . Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump for Treating Cardiogenic Shock: Meta-Analysis. J Am Coll Cardiol. 2016; 69(3):358-360. DOI: 10.1016/j.jacc.2016.10.026. View

17.

Basir M, Schreiber T, Grines C, Dixon S, Moses J, Maini B . Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock. Am J Cardiol. 2017; 119(6):845-851. DOI: 10.1016/j.amjcard.2016.11.037. View

18.

Werdan K, Gielen S, Ebelt H, Hochman J . Mechanical circulatory support in cardiogenic shock. Eur Heart J. 2013; 35(3):156-67. DOI: 10.1093/eurheartj/eht248. View

19.

Sintek M, Gdowski M, Lindman B, Nassif M, Lavine K, Novak E . Intra-Aortic Balloon Counterpulsation in Patients With Chronic Heart Failure and Cardiogenic Shock: Clinical Response and Predictors of Stabilization. J Card Fail. 2015; 21(11):868-76. PMC: 4630130. DOI: 10.1016/j.cardfail.2015.06.383. View

20.

Patel M, Smalling R, Thiele H, Barnhart H, Zhou Y, Chandra P . Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA. 2011; 306(12):1329-37. DOI: 10.1001/jama.2011.1280. View